Home » Healthcare AI News » Currently Reading:

Healthcare AI News 8/30/23

August 30, 2023 Healthcare AI News No Comments



OpenAI releases an enterprise version of ChatGPT that features enhanced security, privacy, and speed. The product overlaps the offerings of the company’s investor Microsoft, which provides a similar offering as part of Azure. The ChatGPT service costs $30 per user per month.

Hackensack Meridian Health will work with Google Cloud on generative AI projects, while HCA Healthcare announces similar plans.



Viz.ai will commercialize three ECG AI algorithms that were developed by UCSF. The algorithms detect cardiac amyloidosis, pulmonary hypertension, and supraventricular tachycardia.


AI-powered, message-based care provider Curai Health joins Amazon Clinic’s virtual care marketplace.


Drug maker Bayer expands its digital therapeutics business with a partnership with Mahana Therapeutics, which offers an FDA-cleared digital product for irritable bowel syndrome.


A consumer research survey finds that 82% of Americans haven’t used ChatGPT, 81% of them don’t expect it to have a major impact on their jobs, and 85% don’t think it can help them do their work.

A study of EHR data in Israel finds that AI can predict food allergies in newborns, surprising researchers who found a significant correlation in the exposure of pregnant women to antibiotics. They conclude that the antibiotics may have interfered with the babies’ microbiome, which influences allergy development.


ChatGPT successfully improves the readability of patient consent forms, researchers find, creating versions that are shorter and easier to read. The required reading level dropped from college freshman to eighth grader.

ChatGPT-generated cancer treatment plans are full of mistakes, researchers find, where one-third of the tested plans contained incorrect information. ChatGPT also mixed correct and incorrect information together in a way that made it hard for even experts to detect.



KFF News headlines a story about Bamboo Health’s NarxCare as “Artificial Intelligence May Influence Whether You Can Get Pain Medication.” The software predicts the likelihood that a patient will overdose based on their documented use of narcotics, sedatives, and stimulants. CDC has warned providers to make sure use of the algorithm doesn’t harm patients, such as turning them away for visits or denying them medications for documented chronic pain, and has voiced concern about “proprietary algorithms” whose methods are not transparent.


A startup sells Nextflix-type subscriptions to access the AI clones of celebrities who earn recurring earnings for doing little more than providing content from elsewhere and setting the guidelines for how their clones will operate. Experts fear the chatbot will worsen loneliness and encourage replacing human interactions with “parasocial” ones. The founders noted the success of a YouTube influencer whose “virtual girlfriend” earned her $71,000 in its first nine days.


Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Contact us.

HIStalk Featured Sponsors


Text Ads


  1. Honestly, I autocorrected "62 Ventures" as "62 Vultures", and I considered posting snark about same! Is that on me? Is…

  2. $20 million to improve behavioral HIT? That's like 1/7th of a typical Epic install in one hospital. Seems like symbolic…

  3. Regarding the Particle Health - Epic Carequality Drama - it's important to note that most existing national networks separate out…

  4. Re: Tullman/62 Ventures Given his track record for acquiring companies, bungling day-to-day operations and then somehow selling to an unwitting…

  5. Was not the struggle of Teladoc foreseeable with the acquisition of Livongo?

Founding Sponsors


Platinum Sponsors










































Gold Sponsors










RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.